Open AccessClinical information and management status of de novo stage IV breast cancer patients: a Chinese multicenter investigation (CSBrS-002)
Author(s) -
Aiping Zheng,
Bin Guo,
Jianguo Zhang,
Feng Jin
Publication year - 2021
Publication title -
chinese medical journal/chinese medical journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.537
H-Index - 63
eISSN - 2542-5641
pISSN - 0366-6999
DOI - 10.1097/cm9.0000000000001415
Subject(s) - medicine , breast cancer , oncology , metastasis , stage (stratigraphy) , cancer , progesterone receptor , estrogen receptor , metastatic breast cancer , gynecology , biology , paleontology
Although de novo stage IV breast cancer is so far incurable, it has entered an era of individualized treatment and chronic disease management. Based on systemic treatment, whether the surgical resection of primary or metastatic foci of de novo stage IV breast cancer can bring survival benefits is currently controversial. We aimed to explore the clinicopathological factors and current status of the management of de novo stage IV breast cancer in China to provide a reference for clinical decisions.